IP Library Granted Patent US 11,932,665
Granted Patent B2
US 11,932,665 · App. 18/147,178 · Granted Mar 19, 2024

Cyclic thiol prodrugs

Inventors: Manoj Chandrasinhji Desai (Martinez, CA); Siva R. Kamma (Hyderabad, IN)
Assignee: Lilac Therapeutics, Inc.
C07F9/65848C07F9/65785
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,932,665
App. No.
18/147,178
Granted
Mar 19, 2024
Kind
B2
Abstract

Disclosed herein are cyclic thiol prodrugs, and pharmaceutical compositions thereof. The prodrugs and pharmaceutical compositions thereof may be used to treat or prevent medical disorders such as, for example, cystinuria, cystinosis, cancer, neurodegenerative disease, Parkinson's disease, Huntington's disease, malaria, nonalcoholic fatty liver disease, radiation poisoning, arsenic poisoning, radioprotection, Wilson's disease or rheumatoid arthritis.

Claims (6)

1. A compound having the structure:

2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable vehicle.

3. A compound having the structure:

4. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable vehicle.

5. A compound having the structure:

6. A pharmaceutical composition comprising the compound of claim 5 and a pharmaceutically acceptable vehicle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2025
From: LILAC THERAPEUTICS, INC.
To: HARP BIO INC.
Reel/Frame 072045/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: DESAI, MANOJ CHANDRASINHJI; KAMMA, SIVA R.
To: LILAC THERAPEUTICS, INC.
Reel/Frame 062845/0523 →
Continuity (2)
Provisional Application 63296057 · Jan 3, 2022
Related Publication 20230234979A1 · Jul 27, 2023